Latest stories on CNXU
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
Business Insider63 · neutralproduct/pr
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
PR Newswire63 · neutralproduct/pr
Conexeu Sciences Inc. (CNXU) files 8-K
SEC 8-K50 · neutralgeneral
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It
PR Newswire63 · neutralproduct/pr
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform | CNXU Stock News
StockTitan63 · neutralproduct/pr
Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission
Seeking Alpha58 · neutralgeneral
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
PR Newswire67 · bullishgeneral
Conexeu Sciences Inc. (CNXU) files 8-K
SEC 8-K50 · neutralgeneral
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program | CNXU Stock News
StockTitan63 · neutralproduct/pr
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
MarketBeat73 · bullishgeneral
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 | CNXU Stock News
StockTitan63 · neutralgeneral
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
PR Newswire63 · neutralproduct/pr
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
PR Newswire63 · neutralproduct/pr
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU" | CNXU Stock News
StockTitan55 · neutralgeneral